Logo image of USLM

UNITED STATES LIME & MINERAL (USLM) Stock Fundamental Analysis

NASDAQ:USLM - Nasdaq - US9119221029 - Common Stock - Currency: USD

100.79  +0.43 (+0.43%)

After market: 100.79 0 (0%)

Fundamental Rating

8

We assign a fundamental rating of 8 out of 10 to USLM. USLM was compared to 12 industry peers in the Construction Materials industry. USLM gets an excellent profitability rating and is at the same time showing great financial health properties. USLM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make USLM a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

10

1. Profitability

1.1 Basic Checks

USLM had positive earnings in the past year.
In the past year USLM had a positive cash flow from operations.
In the past 5 years USLM has always been profitable.
USLM had a positive operating cash flow in each of the past 5 years.
USLM Yearly Net Income VS EBIT VS OCF VS FCFUSLM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 20.59%, USLM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of USLM (22.64%) is better than 91.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.83%, USLM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for USLM is significantly above the industry average of 10.74%.
The 3 year average ROIC (15.83%) for USLM is below the current ROIC(19.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.59%
ROE 22.64%
ROIC 19.83%
ROA(3y)16.44%
ROA(5y)14.23%
ROE(3y)18.33%
ROE(5y)15.98%
ROIC(3y)15.83%
ROIC(5y)14.04%
USLM Yearly ROA, ROE, ROICUSLM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

USLM has a Profit Margin of 35.73%. This is amongst the best in the industry. USLM outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of USLM has grown nicely.
USLM's Operating Margin of 41.23% is amongst the best of the industry. USLM outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of USLM has grown nicely.
The Gross Margin of USLM (47.30%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of USLM has grown nicely.
Industry RankSector Rank
OM 41.23%
PM (TTM) 35.73%
GM 47.3%
OM growth 3Y17.04%
OM growth 5Y15.58%
PM growth 3Y20.51%
PM growth 5Y15.78%
GM growth 3Y13.11%
GM growth 5Y11.59%
USLM Yearly Profit, Operating, Gross MarginsUSLM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), USLM is creating value.
Compared to 1 year ago, USLM has less shares outstanding
USLM has more shares outstanding than it did 5 years ago.
USLM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
USLM Yearly Shares OutstandingUSLM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
USLM Yearly Total Debt VS Total AssetsUSLM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

USLM has an Altman-Z score of 36.04. This indicates that USLM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 36.04, USLM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for USLM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 36.04
ROIC/WACC1.96
WACC10.13%
USLM Yearly LT Debt VS Equity VS FCFUSLM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

USLM has a Current Ratio of 15.29. This indicates that USLM is financially healthy and has no problem in meeting its short term obligations.
USLM's Current ratio of 15.29 is amongst the best of the industry. USLM outperforms 100.00% of its industry peers.
A Quick Ratio of 14.20 indicates that USLM has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 14.20, USLM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.29
Quick Ratio 14.2
USLM Yearly Current Assets VS Current LiabilitesUSLM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.91% over the past year.
USLM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.47% yearly.
USLM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.83%.
Measured over the past years, USLM shows a quite strong growth in Revenue. The Revenue has been growing by 14.95% on average per year.
EPS 1Y (TTM)49.91%
EPS 3Y42.54%
EPS 5Y32.47%
EPS Q2Q%52.28%
Revenue 1Y (TTM)17.83%
Revenue growth 3Y18.85%
Revenue growth 5Y14.95%
Sales Q2Q%27.29%

3.2 Future

USLM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.82% yearly.
The Revenue is expected to grow by 15.26% on average over the next years. This is quite good.
EPS Next Y15.61%
EPS Next 2Y12.41%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue Next Year19.43%
Revenue Next 2Y17.36%
Revenue Next 3Y15.26%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
USLM Yearly Revenue VS EstimatesUSLM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
USLM Yearly EPS VS EstimatesUSLM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

USLM is valuated rather expensively with a Price/Earnings ratio of 24.00.
USLM's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.32, USLM is valued at the same level.
Based on the Price/Forward Earnings ratio of 21.02, the valuation of USLM can be described as rather expensive.
USLM's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of USLM to the average of the S&P500 Index (22.19), we can say USLM is valued inline with the index average.
Industry RankSector Rank
PE 24
Fwd PE 21.02
USLM Price Earnings VS Forward Price EarningsUSLM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

USLM's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, USLM is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.05
EV/EBITDA 15.82
USLM Per share dataUSLM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
USLM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.54
PEG (5Y)0.74
EPS Next 2Y12.41%
EPS Next 3Y11.82%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.24%, USLM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.37, USLM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, USLM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.24%

5.2 History

The dividend of USLM decreases each year by -48.40%.
USLM has been paying a dividend for at least 10 years, so it has a reliable track record.
USLM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-48.4%
Div Incr Years1
Div Non Decr Years4
USLM Yearly Dividends per shareUSLM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

4.99% of the earnings are spent on dividend by USLM. This is a low number and sustainable payout ratio.
DP4.99%
EPS Next 2Y12.41%
EPS Next 3Y11.82%
USLM Yearly Income VS Free CF VS DividendUSLM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
USLM Dividend Payout.USLM Dividend Payout, showing the Payout Ratio.USLM Dividend Payout.PayoutRetained Earnings

UNITED STATES LIME & MINERAL

NASDAQ:USLM (6/17/2025, 8:23:36 PM)

After market: 100.79 0 (0%)

100.79

+0.43 (+0.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29
Inst Owners29.5%
Inst Owner Change5.31%
Ins Owners1%
Ins Owner Change1.01%
Market Cap2.88B
Analysts43.33
Price Target107.1 (6.26%)
Short Float %4.08%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 0.24%
Yearly Dividend0.22
Dividend Growth(5Y)-48.4%
DP4.99%
Div Incr Years1
Div Non Decr Years4
Ex-Date05-23 2025-05-23 (0.06)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24
Fwd PE 21.02
P/S 8.55
P/FCF 28.05
P/OCF 20.86
P/B 5.42
P/tB 5.42
EV/EBITDA 15.82
EPS(TTM)4.2
EY4.17%
EPS(NY)4.79
Fwd EY4.76%
FCF(TTM)3.59
FCFY3.57%
OCF(TTM)4.83
OCFY4.79%
SpS11.79
BVpS18.6
TBVpS18.6
PEG (NY)1.54
PEG (5Y)0.74
Profitability
Industry RankSector Rank
ROA 20.59%
ROE 22.64%
ROCE 24.84%
ROIC 19.83%
ROICexc 42.82%
ROICexgc 42.82%
OM 41.23%
PM (TTM) 35.73%
GM 47.3%
FCFM 30.49%
ROA(3y)16.44%
ROA(5y)14.23%
ROE(3y)18.33%
ROE(5y)15.98%
ROIC(3y)15.83%
ROIC(5y)14.04%
ROICexc(3y)25.43%
ROICexc(5y)22.04%
ROICexgc(3y)25.43%
ROICexgc(5y)22.04%
ROCE(3y)19.83%
ROCE(5y)17.59%
ROICexcg growth 3Y29.36%
ROICexcg growth 5Y25.03%
ROICexc growth 3Y29.36%
ROICexc growth 5Y25.03%
OM growth 3Y17.04%
OM growth 5Y15.58%
PM growth 3Y20.51%
PM growth 5Y15.78%
GM growth 3Y13.11%
GM growth 5Y11.59%
F-Score8
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 146.14%
Cap/Sales 10.51%
Interest Coverage 250
Cash Conversion 84.68%
Profit Quality 85.34%
Current Ratio 15.29
Quick Ratio 14.2
Altman-Z 36.04
F-Score8
WACC10.13%
ROIC/WACC1.96
Cap/Depr(3y)125.99%
Cap/Depr(5y)121.69%
Cap/Sales(3y)10.72%
Cap/Sales(5y)11.72%
Profit Quality(3y)83.68%
Profit Quality(5y)93.5%
High Growth Momentum
Growth
EPS 1Y (TTM)49.91%
EPS 3Y42.54%
EPS 5Y32.47%
EPS Q2Q%52.28%
EPS Next Y15.61%
EPS Next 2Y12.41%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)17.83%
Revenue growth 3Y18.85%
Revenue growth 5Y14.95%
Sales Q2Q%27.29%
Revenue Next Year19.43%
Revenue Next 2Y17.36%
Revenue Next 3Y15.26%
Revenue Next 5YN/A
EBIT growth 1Y52.24%
EBIT growth 3Y39.1%
EBIT growth 5Y32.86%
EBIT Next Year38.81%
EBIT Next 3Y19.12%
EBIT Next 5YN/A
FCF growth 1Y104.91%
FCF growth 3Y56.39%
FCF growth 5Y37.71%
OCF growth 1Y79.73%
OCF growth 3Y31.29%
OCF growth 5Y21.8%